サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519828

結核診断市場レポート：病期、検査タイプ、エンドユーザー、地域別、2024年～2032年

Tuberculosis Diagnostics Market Report by Disease Stage, Test Type, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
結核診断市場レポート：病期、検査タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の結核診断市場規模は2023年に25億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに37億米ドルに達し、2024年から2032年の間に4.2％の成長率（CAGR）を示すと予測しています。

結核は、主に肺を冒し（肺感染症）、その他の部位（肺外感染症）を侵す細菌性感染症です。感染症は、マントゥー・ツベルクリン皮膚テスト（TST）または結核血液検査によって診断されます。結核の確定診断には、感染した臓器によって追加の検査が必要です。肺結核の場合、胸部X線検査で胸部の異常を検出し、喀痰の酸菌染色と顕微鏡検査を行います。肺外結核は、CT、MRI、超音波検査、内視鏡検査、腹腔鏡検査、尿検査、血液検査、生検、腰椎穿刺などで診断することができます。

結核診断市場動向：

世界中で多剤耐性（MDR）結核の有病率が増加していることは、市場の成長を促す重要な要因の一つです。MDR結核は、結核に対する最も強力な抗菌薬の一つと考えられているイソニアジドとリファンピシンに耐性を持つ細菌によって引き起こされます。さらに、技術的に進歩したPOC（Point-of-Care）診断法が利用可能になったことも、市場の成長を後押ししています。核酸増幅検査（NAAT）やインターフェロン-ガンマ放出アッセイ（IGRA）のような高度な診断法は、従来使用されてきた手法と比較して、より正確で便利であり、迅速な結果が得られます。さらに、ヘルスケア・インフラの大幅な改善と、様々な診断方法に対する大衆の意識の高まりが、もう一つの成長促進要因として作用しています。その他の要因としては、高齢人口の増加、医療費の増加、研究開発（R&D）活動を促進するための政府の取り組みや投資などがあり、市場をさらに牽引すると予測されています。

本レポートで扱う主な質問

  • 世界の結核診断市場はこれまでどのように推移し、今後どのように推移していくのか
  • 主要な地域市場はどこか
  • 世界の結核診断市場に与えたCOVID-19の影響は何か
  • 疾患ステージに基づく市場の内訳は何か
  • 検査タイプに基づく市場の内訳は何か
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界における主要な促進要因と課題とは？
  • 世界の結核診断市場の構造と主要プレイヤーとは？
  • 業界における競合の程度とは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の結核診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：病期別

  • 潜在性結核
    • 市場動向
    • 市場予測
  • 活動性結核
    • 市場動向
    • 市場予測

第7章 市場内訳：検査タイプ別

  • 放射線検査
    • 市場動向
    • 市場予測
  • ラボ検査
    • 市場動向
    • 主な種類
      • 塗抹顕微鏡検査
      • 培養ベース検査
    • 市場予測
  • 核酸検査
    • 市場動向
    • 市場予測
  • サイトカイン検出検査
    • 市場動向
    • 市場予測
  • 薬剤耐性検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院と診療所
    • 市場動向
    • 市場予測
  • 診断および調査ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Alere Inc.
    • Becton Dickinson and Company
    • BioMerieux
    • Cepheid Inc.
    • Epistem Ltd.
    • Roche Holding AG
    • Hain Lifescience GmbH
    • Hologic Inc.
    • QIAGEN GmbH
    • Siemens
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2023
  • Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Tuberculosis Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2024-2032
  • Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
  • Table 7: Global: Tuberculosis Diagnostics Market: Key Players
目次
Product Code: SR112024A2047

The global tuberculosis diagnostics market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient's sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

Tuberculosis Diagnostics Market Trends:

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disease stage, test type, and end-user.

Breakup by Disease Stage:

Latent TB

Active TB

Breakup by Test Type:

Radiographic Test

Laboratory Test

Smear Microscopy

Culture-based Test

Nucleic Acid Testing

Cytokine Detection Test

Drug Resistance Test

Others

Breakup by End-User:

Hospitals and Clinics

Diagnostics and Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMerieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tuberculosis Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Stage

  • 6.1 Latent TB
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Active TB
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Radiographic Test
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Smear Microscopy
      • 7.2.2.2 Culture-based Test
    • 7.2.3 Market Forecast
  • 7.3 Nucleic Acid Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cytokine Detection Test
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Drug Resistance Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Research Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alere Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Epistem Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Roche Holding AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Hain Lifescience GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis